Categories: News

Avinger to Announce Third Quarter 2024 Results on November 7, 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

REDWOOD CITY, CA / ACCESSWIRE / October 29, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the third quarter 2024 after the close of trading on Thursday, November 7, 2024. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.

To join the call by telephone, please dial +1- 973-528-0011 and use passcode 442577. A live webcast of the conference call will be available online from the investor relations page of the Company’s corporate website at www.avinger.com.

A replay of the webcast will be made available on Avinger’s website, www.avinger.com, shortly after completion of the call.

About Avinger, Inc.
Avinger is a commercial-stage medical device company that designs and develops the first image-guided, catheter-based system for the diagnosis and treatment of patients with vascular disease in the peripheral and coronary arteries. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox series of imaging consoles, the Ocelot and Tigereye® family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices for the treatment of peripheral artery disease (PAD), estimated to affect more than 200 million people worldwide. Avinger is developing its first product application for the treatment of coronary artery disease (CAD), an image-guided system for CTO-crossing in the coronary arteries, which provides the opportunity to redefine a large and underserved market. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Follow Avinger on X and Facebook.

Investor Contact:
Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.

View the original press release on accesswire.com

Staff

Recent Posts

Netsmart Showcases Meaningful AI and New Innovations of the CareFabric® Platform to Optimize Community-Based Care at NatCon25

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#Acquisition--Netsmart, an industry-leading provider of healthcare IT for human services and post-acute…

3 hours ago

AV Laboratories Appoints Roula Youssef Halabi to Business Advisory Board to Expand Presence in UAE and Middle East

NEW YORK--(BUSINESS WIRE)--AV Laboratories, a leader in science-backed skincare and luxury skin longevity, proudly announces…

3 hours ago

Eight Student Teams Named National Winners of 33rd Annual ExploraVision Competition

Toshiba and the National Science Teaching Association (NSTA) honor student innovation with prizes and award…

3 hours ago

Psomagen Selected as Key Service Provider, Will Utilize Ultima Genomics’ UG 100™ Sequencer to Accelerate Chan Zuckerberg Initiative’s Billion Cells Project

ROCKVILLE, Md., May 5, 2025 /PRNewswire/ -- Psomagen Inc., a multiomics service laboratory serving academic,…

3 hours ago

Arctic Quest: 8,000-Mile Motorcycle Ride Honors Indigenous Women and Girls

Our Rescue, Mental Health Tech Company and First Nations Advocate Unite to Raise Awareness and…

3 hours ago

Digital Twins in Healthcare Market worth US$59.94 billion by 2030 with 68.0% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., May 5, 2025 /PRNewswire/ -- The global Digital Twins in Healthcare Market,…

3 hours ago